لخّصلي

Chronic kidney disease (CKD) is defined as abnormal?ities of kidney function or structure that persist for >3 months and have health implications.1 The worldwide (C) 2021 American Society for Parenteral and Enteral Nutrition prevalence of CKD is estimated to be 9.1%.2 A diagno?sis of CKD is correlated with higher risks of cardiovas?cular and all-cause mortality, acute kidney injury, and CKD progression, among other comorbidities.1 Patients with CKD, especially those approaching end-stage kidney failure and undergoing maintenance dialysis, frequently experience gradual decline in their nutrition status; the latter is typified by such deranged metabolic and nutri?tion status changes3 displayed as concurrent depletion of body protein and energy reserves, eventually result?ing in fat and muscle wasting, in addition to shrinkage of visceral protein pool.4-6 This state of disorder, coined as protein-energy wasting (PEW), has a worldwide preva?lence of 11%-54% and 28%-54% in patients who have stages 3-5 non-dialysis-dependent CKD or require maintenance dialysis,7 respectively.In addition, insufficient dietary intake of energy and pro?tein can stem from dietary restrictions, comorbidities that affect the gastrointestinal function, low socioeconomic sta?tus, depression, physical disability that hampers food pro?vision and preparation, and factors pertaining to peritoneal dialysis, such as abdominal discomfort, peritoneal glu?cose absorption, and early satiety with peritoneal dialysate infusion.3,13,14 Furthermore, the pathophysiology of PEW can be caused by other highly common factors, including a low level of physical activity, endocrine derangements, metabolic abnormalities, and dialysis-specific catabolism and nutrient losses.3,13-16 Although the obligatory losses of water-soluble vitamins, proteins, and amino acids are known to occur during both peritoneal dialysis and hemodialysis processes,15,16 the losses of energy and glu?cose are highly applicable during the hemodialysis pro?cess, as glucose is replenished via the peritoneal route.15,16 Notably, increased protein catabolism and inflammation induced by dialysis were evident in both peritoneal dial?ysis and hemodialysis patients,15-17 though the effect of catabolism was found to be higher in the latter, with the exception of those with peritonitis.15 Eventually, PEW may lead to cardiovascular diseases, infections, frailty, and depression, with these complications exacerbating PEW.3,13 In spite of the multifactorial attributions of PEW, it is realized that many of the causative factors are related to decreased nutrient intake,5 as indicated in Figure 1.The International Society of Renal Nutrition and Metabolism (ISRNM) proposed an etiological model for PEW (Figure 1).3,12,13 A crucial factor in the etiology of PEW is insufficient oral intake of energy and protein owing to anorexia, as a consequence of the dialysis process, retained uremic toxins, inflammation, metabolic acidosis, and intercurrent illnesses.3,13 Concurrently, these condi?tions are independently related to the progression of PEW.This review article aims to focus on different nutrition sup?port approaches in the treatment of PEW in CKD, includ?ing nutrition counseling, oral nutrition supplementation, enteral tube feeding, partial parenteral nutrition (PN) ther?apies such as intraperitoneal PN (IPPN) and intradialytic PN (IDPN), and total PN, in addition to providing the rec?ommended goals for nutrition support.Of importance, the prevalence of PEW increases with dialysis vintage,8-10 contributing sub?stantially to increased morbidity and mortality and nega?tively impacting quality of life.3,11 The potential causes of PEW in CKD are compli?cated.

Chronic kidney disease (CKD) is defined as abnormal￾ities of kidney function or structure that persist for >3
months and have health implications.1 The worldwide
© 2021 American Society for Parenteral and Enteral Nutrition
prevalence of CKD is estimated to be 9.1%.2 A diagno￾sis of CKD is correlated with higher risks of cardiovas￾cular and all-cause mortality, acute kidney injury, and
CKD progression, among other comorbidities.1 Patients
with CKD, especially those approaching end-stage kidney failure and undergoing maintenance dialysis, frequently
experience gradual decline in their nutrition status; the
latter is typified by such deranged metabolic and nutri￾tion status changes3 displayed as concurrent depletion
of body protein and energy reserves, eventually result￾ing in fat and muscle wasting, in addition to shrinkage
of visceral protein pool.4–6 This state of disorder, coined
as protein-energy wasting (PEW), has a worldwide preva￾lence of 11%–54% and 28%–54% in patients who have stages
3–5 non–dialysis-dependent CKD or require maintenance
dialysis,7 respectively. Of importance, the prevalence of
PEW increases with dialysis vintage,8–10 contributing sub￾stantially to increased morbidity and mortality and nega￾tively impacting quality of life.3,11
The potential causes of PEW in CKD are compli￾cated. The International Society of Renal Nutrition and
Metabolism (ISRNM) proposed an etiological model for
PEW (Figure 1).3,12,13 A crucial factor in the etiology of
PEW is insufficient oral intake of energy and protein
owing to anorexia, as a consequence of the dialysis process,
retained uremic toxins, inflammation, metabolic acidosis,
and intercurrent illnesses.3,13 Concurrently, these condi￾tions are independently related to the progression of PEW.
In addition, insufficient dietary intake of energy and pro￾tein can stem from dietary restrictions, comorbidities that
affect the gastrointestinal function, low socioeconomic sta￾tus, depression, physical disability that hampers food pro￾vision and preparation, and factors pertaining to peritoneal
dialysis, such as abdominal discomfort, peritoneal glu￾cose absorption, and early satiety with peritoneal dialysate
infusion.3,13,14 Furthermore, the pathophysiology of PEW
can be caused by other highly common factors, including
a low level of physical activity, endocrine derangements,
metabolic abnormalities, and dialysis-specific catabolism
and nutrient losses.3,13–16 Although the obligatory losses
of water-soluble vitamins, proteins, and amino acids
are known to occur during both peritoneal dialysis and
hemodialysis processes,15,16 the losses of energy and glu￾cose are highly applicable during the hemodialysis pro￾cess, as glucose is replenished via the peritoneal route.15,16
Notably, increased protein catabolism and inflammation
induced by dialysis were evident in both peritoneal dial￾ysis and hemodialysis patients,15–17 though the effect of
catabolism was found to be higher in the latter, with
the exception of those with peritonitis.15 Eventually, PEW
may lead to cardiovascular diseases, infections, frailty,
and depression, with these complications exacerbating
PEW.3,13
In spite of the multifactorial attributions of PEW, it is
realized that many of the causative factors are related to
decreased nutrient intake,5 as indicated in Figure 1. In fact,
nutrition support therapy can rectify many signs of PEW.
This review article aims to focus on different nutrition sup￾port approaches in the treatment of PEW in CKD, includ￾ing nutrition counseling, oral nutrition supplementation,
enteral tube feeding, partial parenteral nutrition (PN) ther￾apies such as intraperitoneal PN (IPPN) and intradialytic
PN (IDPN), and total PN, in addition to providing the rec￾ommended goals for nutrition support.